Implementation of Overdose Prevention in Maryland: Implications for Resource Allocation, Program Scale-Up, and Evaluation.

evaluation methods implementation mortality overdose public health laws/policies substance use

Journal

Health promotion practice
ISSN: 1524-8399
Titre abrégé: Health Promot Pract
Pays: United States
ID NLM: 100890609

Informations de publication

Date de publication:
22 Nov 2023
Historique:
medline: 22 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: aheadofprint

Résumé

Overdose mortality in the United States continues to climb, with Maryland being one of the hardest hit states. We summarized implementation of overdose prevention and response programs in Maryland and identified associations between opioid overdose deaths by jurisdiction in 2019 and implementation of overdose programs by 2021. Data on program implementation are from Maryland's Opioid Operational Command Center (OOCC) Program Inventory. OOCC coordinates the state's response to overdose, and their Program Inventory tracks implementation of 145 programs across 12 domains (e.g., public health, education, and judiciary), including 10 programs designed to broaden naloxone access. The level of program implementation was dichotomized as substantial implementation versus other levels (i.e., partial, planned, and none). We estimated associations between per capita opioid overdose deaths and substantial implementation of: all 145 programs in the Inventory, programs within each of 12 domains, and 10 naloxone programs. Data on program implementation and overdose mortality are summarized at the jurisdiction level. Across jurisdictions, the median proportion of programs with substantial implementation was 51% across all programs and 70% among naloxone programs. Overdose mortality was associated with subsequent substantial implementation of programs within the public health domain (

Identifiants

pubmed: 37991198
doi: 10.1177/15248399231209935
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15248399231209935

Auteurs

Catherine Tomko (C)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Saba Rouhani (S)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Renee M Johnson (RM)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Ryoko Susukida (R)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Himani Byregowda (H)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Taylor Parnham (T)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Kristin E Schneider (KE)

Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Marianne Gibson (M)

Maryland Opioid Operational Command Center, Baltimore, MD, USA.

Teresa Heath (T)

Maryland Opioid Operational Command Center, Baltimore, MD, USA.

Robin Rickard (R)

Maryland Opioid Operational Command Center, Baltimore, MD, USA.

Christine E Boyd (CE)

Maryland Department of Health, Baltimore, MD, USA.

Ju Nyeong Park (JN)

Alpert Medical School, Brown University, Providence, RI, USA.

Classifications MeSH